Matrix Mediated Viral Gene Delivery: A Review

被引:10
|
作者
Steinhaufft, Douglas [1 ,3 ]
Ghandehari, Hamidreza [1 ,2 ,3 ]
机构
[1] Univ Utah, Dept Biomed Engn, 36 South Wasatch Dr, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, 36 South Wasatch Dr, Salt Lake City, UT 84112 USA
[3] Nano Inst Utah, Utah Ctr Nanomed, 36 South Wasatch Dr, Salt Lake City, UT 84112 USA
基金
美国国家卫生研究院;
关键词
ELASTINLIKE PROTEIN POLYMER; MESENCHYMAL STEM-CELLS; IN-VIVO EVALUATION; ADENOASSOCIATED VIRUS SEROTYPE-2; LOCALIZED LENTIVIRUS DELIVERY; BONE MORPHOGENETIC PROTEIN-7; MATURE VACCINIA VIRUS; CONTROLLED-RELEASE; RECOMBINANT ADENOVIRUS; FIBRIN SCAFFOLD;
D O I
10.1021/acs.bioconjchem.8b00853
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Polymeric matrices inherently protect viral vectors from preexisting immune conditions, limit dissemination to off-target sites, and can sustain vector release. Advancing methodologies in development of particulate based vehicles have led to improved encapsulation of viral vectors. Polymeric delivery systems have contributed to increasing cellular transduction, responsive release mechanisms, cellular infiltration, and cellular signaling. Synthetic polymers are easily customizable, and are capable of balancing matrix retention with cellular infiltration. Natural polymers contain inherent biorecognizable motifs adding therapeutic efficacy to the incorporated viral vector. Recombinant polymers use highly conserved motifs to carefully engineer matrices, allowing for precise design including elements of vector retention and responsive release mechanisms. Composite polymer systems provide opportunities to create matrices with unique properties. Carefully designed matrices can control spatiotemporal release patterns that synergize with approaches in regenerative medicine and antitumor therapies.
引用
收藏
页码:384 / 399
页数:16
相关论文
共 50 条
  • [31] Microglial Barriers to Viral Gene Delivery
    Pluvinage, John V.
    Wyss-Coray, Tony
    NEURON, 2017, 93 (03) : 468 - 470
  • [32] Non viral gene delivery techniques
    Scherman, Daniel
    HUMAN GENE THERAPY, 2012, 23 (10) : A4 - A5
  • [33] Non-viral gene delivery
    Behr, JP
    EUROCANCER 98, 1998, : 255 - 256
  • [34] Viral gene delivery methods for the cornea
    Liu, J
    Tuli, SS
    Lewin, AS
    Bloom, DC
    Hauswirth, WW
    Schultz, GS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [35] Materials promoting viral gene delivery
    Kaygisiz, Kuebra
    Synatschke, Christopher, V
    BIOMATERIALS SCIENCE, 2020, 8 (22) : 6113 - 6156
  • [36] Interplay of cell adhesion matrix stiffness and cell type for non-viral gene delivery
    Chu, Cathy
    Kong, Hyunjoon
    ACTA BIOMATERIALIA, 2012, 8 (07) : 2612 - 2619
  • [37] Effective Cutaneous Gene Delivery through Dissolvable Microneedle Mediated Intradermal Delivery of Adeno-Associated Viral Vectors
    Ackerman, D. S.
    Falo, G. D.
    Ozdoganlar, D.
    Yalcintas, E. P.
    Tuzmen, C.
    Naganbabu, M.
    Erdos, G.
    Korkmaz, E.
    Falo, L. D., Jr.
    Jarvik, J. W.
    Campbell, P. G.
    Bruchez, M. P.
    Ozdoganlar, O. B.
    TISSUE ENGINEERING PART A, 2017, 23 : S147 - S147
  • [38] MATRIX MEDIATED DELIVERY OF CANCER CHEMOTHERAPEUTICS
    BROWN, DM
    LUCK, EE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 419 - 419
  • [39] The biological routes of gene delivery mediated by lipid-based non-viral vectors
    Duan, Yan
    Zhang, Shubiao
    Wang, Bing
    Yang, Baoling
    Zhi, Defu
    EXPERT OPINION ON DRUG DELIVERY, 2009, 6 (12) : 1351 - 1361
  • [40] In vivo plasmid-mediated gene delivery achieves viral efficiencies via intravascular ultrasound
    Amabile, PG
    Waugh, JM
    Lewis, TN
    Janas, T
    Dake, MD
    CIRCULATION, 2000, 102 (18) : 147 - 147